U.S. Point Of Care Infectious Disease Testing Market Size & Outlook

Name: U.S. Point Of Care Infectious Disease Testing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The point of care infectious disease testing market in the United States is expected to reach a projected revenue of US$ 5,571.9 million by 2033. A compound annual growth rate of 1.59% is expected of the United States point of care infectious disease testing market from 2026 to 2033.

U.S. point of care infectious disease testing type outlook (Revenue, USD million, 2021-2033)
- POC Rapid Diagnostic Single-test
- POC Rapid Diagnostic Combo-test
U.S. point of care infectious disease testing disease outlook (Revenue, USD million, 2021-2033)
- HIV POC
- Chlamydia & Gonorrhea
- Adenovirus
- Rotavirus
- Norovirus
- Shigella
- Dengue
- Zika
- Typhoid
- Syphilis
- Malaria
- Anti-TP (Treponema pallidum)
- Monkeypox
- Strep A
- H. pylori
- HBV POC
- Pneumonia Or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB & Drug-resistant TB POC
- HSV POC
- COVID-19
- Other Infectious Diseases
U.S. point of care infectious disease testing end use outlook (Revenue, USD million, 2021-2033)
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory

U.S. Point Of Care Infectious Disease Testing Market Size & Outlook

Sign up - it's easy, and free!